Straumann Holding continues its bullish trend in order to test new highest level.
The Swiss dental company shows strong fundamentals. It has recently reported its third quarter results which exhibited a solid nine-month growth with acceleration in Q3: revenues climbed by 5% with an operating profit margin above 20%. EPS are increasing each year from CHF 2.36 in 2012 to 8.32 expected in 2014.
Technically, the security shows a bullish configuration on all time scales. Prices are following an upward trendline and supported by increasing moving averages. In weekly data, 20-week moving average helps the stock to keep its uptrend.
According to both technical and fundamental elements, it seems opportune to open a long position above CHF 237. The target price will be set at CHF 260 and a stop loss will be placed around CHF 227.
Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Groupâs headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
STRAUMANN HOLDING AG 
